Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

MannKind Corp (NASDAQ:MNKD)

0.65
Delayed Data
As of Jan 19
 -0.0203 / -3.03%
Today’s Change
0.41
Today|||52-Week Range
2.24
+2.09%
Year-to-Date
MannKind Has a New Plan, but Will It Work?
Jan 18 / MotleyFool.com - Paid Partner Content
Is MannKind Corp. Ready to Rebound in 2017?
Jan 09 / MotleyFool.com - Paid Partner Content

Today’s Trading

Previous close0.67
Today’s open0.65
Day’s range0.63 - 0.67
Volume2,987,349
Average volume (3 months)4,705,527
Market cap$320.7M
Dividend yield--
Data as of 01/19/2017

Growth & Valuation

Earnings growth (last year)-78.43%
Earnings growth (this year)+113.19%
Earnings growth (next 5 years)+26.80%
Revenue growth (last year)--
P/E ratioNM
Price/Sales--
Price/Book--

Competitors

 Today’s
change
Today’s
% change
CRBPCorbus Pharmaceutica...-0.25-3.45%
SRNESorrento Therapeutic...-0.20-3.64%
TRVNTrevena Inc-0.02-0.32%
CARACara Therapeutics In...-0.29-2.44%
Data as of 01/19/2017

Financials

Next reporting dateMarch 20, 2017
EPS forecast (this quarter)-$0.03
Annual revenue (last year)$0.00
Annual profit (last year)-$368.4M
Net profit margin--

Profile

Sector
Health Technology
Industry
Biotechnology
CEO, CFO, Director, VP &
Head-Investor Relations
Matthew J. Pfeffer
Chief Medical Officer &
Vice President
Raymond W. Urbanski
Corporate headquarters
Valencia, California

Forecasts


Search for Jobs